List of Tables
Table 1. Global Antitumor ADC Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Antitumor ADC Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Antitumor ADC Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antitumor ADC Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Antitumor ADC Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Antitumor ADC Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Antitumor ADC Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Antitumor ADC Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Antitumor ADC Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antitumor ADC Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antitumor ADC Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Antitumor ADC Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antitumor ADC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antitumor ADC Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antitumor ADC Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Antitumor ADC Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Antitumor ADC Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Antitumor ADC Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Antitumor ADC Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Antitumor ADC Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Antitumor ADC Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Antitumor ADC Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Antitumor ADC Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Antitumor ADC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Antitumor ADC Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Antitumor ADC Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Antitumor ADC Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Antitumor ADC Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Antitumor ADC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Antitumor ADC Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Antitumor ADC Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Antitumor ADC Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Antitumor ADC Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Antitumor ADC Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Antitumor ADC Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Antitumor ADC Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Antitumor ADC Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Antitumor ADC Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antitumor ADC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Antitumor ADC Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Antitumor ADC Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Antitumor ADC Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antitumor ADC Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Antitumor ADC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Antitumor ADC Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Antitumor ADC Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Antitumor ADC Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Antitumor ADC Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Antitumor ADC Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Antitumor ADC Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Antitumor ADC Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Antitumor ADC Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Antitumor ADC Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Antitumor ADC Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Antitumor ADC Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Antitumor ADC Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Antitumor ADC Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Antitumor ADC Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Antitumor ADC Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Antitumor ADC Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Antitumor ADC Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Antitumor ADC Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Antitumor ADC Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Antitumor ADC Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Antitumor ADC Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Antitumor ADC Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Antitumor ADC Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Antitumor ADC Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Seattle Medical Associates Company Information
Table 71. Seattle Medical Associates Description and Business Overview
Table 72. Seattle Medical Associates Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Seattle Medical Associates Antitumor ADC Drugs Product
Table 74. Seattle Medical Associates Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Roche Antitumor ADC Drugs Product
Table 79. Roche Recent Developments/Updates
Table 80. Daiichi Sankyo Company Information
Table 81. Daiichi Sankyo Description and Business Overview
Table 82. Daiichi Sankyo Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Daiichi Sankyo Antitumor ADC Drugs Product
Table 84. Daiichi Sankyo Recent Developments/Updates
Table 85. Immunomedics Company Information
Table 86. Immunomedics Description and Business Overview
Table 87. Immunomedics Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Immunomedics Antitumor ADC Drugs Product
Table 89. Immunomedics Recent Developments/Updates
Table 90. GSK Company Information
Table 91. GSK Description and Business Overview
Table 92. GSK Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. GSK Antitumor ADC Drugs Product
Table 94. GSK Recent Developments/Updates
Table 95. Rakuten Medical Company Information
Table 96. Rakuten Medical Description and Business Overview
Table 97. Rakuten Medical Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Rakuten Medical Antitumor ADC Drugs Product
Table 99. Rakuten Medical Recent Developments/Updates
Table 100. ADC Therapeutics Company Information
Table 101. ADC Therapeutics Description and Business Overview
Table 102. ADC Therapeutics Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. ADC Therapeutics Antitumor ADC Drugs Product
Table 104. ADC Therapeutics Recent Developments/Updates
Table 105. RemeGen Company Information
Table 106. RemeGen Description and Business Overview
Table 107. RemeGen Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. RemeGen Antitumor ADC Drugs Product
Table 109. RemeGen Recent Developments/Updates
Table 110. Genmab Company Information
Table 111. Genmab Description and Business Overview
Table 112. Genmab Antitumor ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Genmab Antitumor ADC Drugs Product
Table 114. Genmab Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Antitumor ADC Drugs Distributors List
Table 118. Antitumor ADC Drugs Customers List
Table 119. Antitumor ADC Drugs Market Trends
Table 120. Antitumor ADC Drugs Market Drivers
Table 121. Antitumor ADC Drugs Market Challenges
Table 122. Antitumor ADC Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antitumor ADC Drugs
Figure 2. Global Antitumor ADC Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antitumor ADC Drugs Market Share by Type: 2024 & 2031
Figure 4. DNA Damaging Drugs Product Picture
Figure 5. Tubulin Inhibitors Product Picture
Figure 6. Global Antitumor ADC Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Antitumor ADC Drugs Market Share by Application: 2024 & 2031
Figure 8. Breast Cancer
Figure 9. Lymphoma
Figure 10. Other
Figure 11. Global Antitumor ADC Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Antitumor ADC Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Antitumor ADC Drugs Sales (2020-2031) & (K Units)
Figure 14. Global Antitumor ADC Drugs Average Price (US$/Unit) & (2020-2031)
Figure 15. Antitumor ADC Drugs Report Years Considered
Figure 16. Antitumor ADC Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Antitumor ADC Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Antitumor ADC Drugs Players: Market Share by Revenue in Antitumor ADC Drugs in 2024
Figure 19. Antitumor ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Antitumor ADC Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Antitumor ADC Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Antitumor ADC Drugs Revenue Market Share by Country (2020-2031)
Figure 23. United States Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Antitumor ADC Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Antitumor ADC Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Antitumor ADC Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Antitumor ADC Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Antitumor ADC Drugs Sales Market Share by Country (2020-2031)
Figure 42. Latin America Antitumor ADC Drugs Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Antitumor ADC Drugs Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Antitumor ADC Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Antitumor ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Antitumor ADC Drugs by Type (2020-2031)
Figure 52. Global Revenue Market Share of Antitumor ADC Drugs by Type (2020-2031)
Figure 53. Global Antitumor ADC Drugs Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Antitumor ADC Drugs by Application (2020-2031)
Figure 55. Global Revenue Market Share of Antitumor ADC Drugs by Application (2020-2031)
Figure 56. Global Antitumor ADC Drugs Price (US$/Unit) by Application (2020-2031)
Figure 57. Antitumor ADC Drugs Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
